Mismatch between iodine-123 IMP and technetium-99m HM-PAO brain perfusion imaging in a patient with meningioma
Journal Article
·
· Clin. Nucl. Med.; (United States)
The discrepancy between three methods for cerebral perfusion imagings in the case of a man with meningioma is presented. Imaging with N-isopropyl-P-(I-123) iodoamphetamine (IMP) showed no activity in the tumor. Imaging with Tc-99m hexamethylpropyleneamine oxime (HM-PAO) and the local cerebral blood flow (LCBF) image with Xe-133 inhalation showed high tumor activity. IMP is a more accurate method for imaging the brain tissue blood flow.
- Research Organization:
- Miyazaki Medical College, Kihara, Japan
- OSTI ID:
- 5782138
- Journal Information:
- Clin. Nucl. Med.; (United States), Vol. 12:9
- Country of Publication:
- United States
- Language:
- English
Similar Records
Dynamic SPECT with technetium-99m HM-PAO in meningiomas--a comparison with iodine-123 IMP
Comparative study of regional cerebral blood flow images by SPECT using xenon-133, iodine-123 IMP, and technetium-99m HM-PAO
Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT--a comparison with iodine-123 HIPDM
Journal Article
·
Thu Jun 01 00:00:00 EDT 1989
· J. Nucl. Med.; (United States)
·
OSTI ID:5782138
+2 more
Comparative study of regional cerebral blood flow images by SPECT using xenon-133, iodine-123 IMP, and technetium-99m HM-PAO
Journal Article
·
Wed Feb 01 00:00:00 EST 1989
· J. Nucl. Med.; (United States)
·
OSTI ID:5782138
+2 more
Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT--a comparison with iodine-123 HIPDM
Journal Article
·
Mon Dec 01 00:00:00 EST 1986
· J. Nucl. Med.; (United States)
·
OSTI ID:5782138
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
BRAIN
BLOOD FLOW
NEOPLASMS
IMAGE PROCESSING
COMPARATIVE EVALUATIONS
DIAGNOSIS
AMPHETAMINES
IODINE 123
ISOMERIC NUCLEI
ORGANOMETALLIC COMPOUNDS
OXIMES
PATIENTS
PERFUSED ORGANS
TECHNETIUM 99
XENON 133
AMINES
ANALEPTICS
AUTONOMIC NERVOUS SYSTEM AGENTS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CENTRAL NERVOUS SYSTEM
CENTRAL NERVOUS SYSTEM AGENTS
DAYS LIVING RADIOISOTOPES
DISEASES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
EVEN-ODD NUCLEI
HOURS LIVING RADIOISOTOPES
HYDROXY COMPOUNDS
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IODINE ISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
NERVOUS SYSTEM
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANS
PROCESSING
RADIOISOTOPES
SYMPATHOMIMETICS
TECHNETIUM ISOTOPES
XENON ISOTOPES
YEARS LIVING RADIOISOTOPES
550601* - Medicine- Unsealed Radionuclides in Diagnostics
BRAIN
BLOOD FLOW
NEOPLASMS
IMAGE PROCESSING
COMPARATIVE EVALUATIONS
DIAGNOSIS
AMPHETAMINES
IODINE 123
ISOMERIC NUCLEI
ORGANOMETALLIC COMPOUNDS
OXIMES
PATIENTS
PERFUSED ORGANS
TECHNETIUM 99
XENON 133
AMINES
ANALEPTICS
AUTONOMIC NERVOUS SYSTEM AGENTS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CENTRAL NERVOUS SYSTEM
CENTRAL NERVOUS SYSTEM AGENTS
DAYS LIVING RADIOISOTOPES
DISEASES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
EVEN-ODD NUCLEI
HOURS LIVING RADIOISOTOPES
HYDROXY COMPOUNDS
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IODINE ISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
NERVOUS SYSTEM
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANS
PROCESSING
RADIOISOTOPES
SYMPATHOMIMETICS
TECHNETIUM ISOTOPES
XENON ISOTOPES
YEARS LIVING RADIOISOTOPES
550601* - Medicine- Unsealed Radionuclides in Diagnostics